{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:08:08Z","timestamp":1791317288070,"version":"4.3.1"},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T00:00:00Z","timestamp":1369008000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0063384","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T21:11:29Z","timestamp":1369084289000},"page":"e63384","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Recombinant Rabies Viruses Expressing GM-CSF or Flagellin Are Effective Vaccines for Both Intramuscular and Oral Immunizations"],"prefix":"10.1371","volume":"8","author":[{"given":"Ming","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement W.","family":"Gnanadurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Leyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen F.","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,5,20]]},"reference":[{"key":"ref1","article-title":"Rabies and rabies research: past, present and future","volume":"15","author":"ZF Fu","year":"1997","journal-title":"Vaccine"},{"key":"ref2","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"DL Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3201\/eid0104.950401","article-title":"The ascension of wildlife rabies: a cause for public health concern or intervention?","volume":"1","author":"CE Rupprecht","year":"1995","journal-title":"Emerg Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1592\/phco.29.10.1182","article-title":"Overview, prevention, and treatment of rabies","volume":"29","author":"AJ Nigg","year":"2009","journal-title":"Pharmacotherapy"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1073\/pnas.93.11.5653","article-title":"Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America","volume":"93","author":"K Morimoto","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","first-page":"777","article-title":"U.s-acquired human rabies with symptom onset and diagnosis abroad, 2012","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1586\/erv.11.140","article-title":"From brain passage to cell adaptation: the road of human rabies vaccine development","volume":"10","author":"X Wu","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00343220","article-title":"The serological response of young dogs to the Flury LEP strain of rabies virus vaccine","volume":"14","author":"HO Aghomo","year":"1990","journal-title":"Vet Res Commun"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2460\/javma.1996.208.11.1827","article-title":"Postexposure rabies prophylaxis and preexposure rabies vaccination failure in domestic animals","volume":"208","author":"KA Clark","year":"1996","journal-title":"J Am Vet Med Assoc"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2334-1-23","article-title":"Field trial with oral vaccination of dogs against rabies in the Philippines","volume":"1","author":"R Estrada","year":"2001","journal-title":"BMC Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S654","DOI":"10.1093\/clinids\/10.Supplement_4.S654","article-title":"Current oral rabies vaccination in Europe: an interim balance","volume":"10","author":"LG Schneider","year":"1988","journal-title":"Rev Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"S649","DOI":"10.1093\/clinids\/10.Supplement_4.S649","article-title":"Oral immunization of wildlife against rabies: concept and first field experiments","volume":"10","author":"AI Wandeler","year":"1988","journal-title":"Rev Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/oxfordjournals.aje.a112302","article-title":"Oral rabies vaccine: evaluation of its infectivity in three species of rodents","volume":"104","author":"WG Winkler","year":"1976","journal-title":"Am J Epidemiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2460\/javma.1982.180.11.1336","article-title":"Vaccine-induced rabies in four cats","volume":"180","author":"JB Esh","year":"1982","journal-title":"J Am Vet Med Assoc"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0264-410X(94)90095-7","article-title":"Vaccination against rabies: construction and characterization of SAG2, a double avirulent derivative of SADBern","volume":"12","author":"F Lafay","year":"1994","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0966-842X(93)90010-O","article-title":"Avirulent mutants of rabies virus and their use as live vaccine","volume":"1","author":"A Flamand","year":"1993","journal-title":"Trends Microbiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e1535","DOI":"10.1371\/journal.pntd.0001535","article-title":"Eliminating rabies in Estonia","volume":"6","author":"F Cliquet","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref18","first-page":"185","article-title":"Elimination of terrestrial rabies in Western European countries","volume":"119","author":"F Cliquet","year":"2004","journal-title":"Dev Biol (Basel)"},{"key":"ref19","first-page":"145","article-title":"First oral vaccination of wildlife against rabies in Estonia","volume":"125","author":"E Niin","year":"2006","journal-title":"Dev Biol (Basel)"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.7589\/0090-3558-38.2.420","article-title":"Oral efficacy of an attenuated rabies virus vaccine in skunks and raccoons","volume":"38","author":"CA Hanlon","year":"2002","journal-title":"J Wildl Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/312163a0","article-title":"Expression of rabies virus glycoprotein from a recombinant vaccinia virus","volume":"312","author":"MP Kieny","year":"1984","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/354520a0","article-title":"Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine","volume":"354","author":"B Brochier","year":"1991","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2460\/javma.1998.212.04.498","article-title":"Results of an oral rabies vaccination program for coyotes","volume":"212","author":"MG Fearneyhough","year":"1998","journal-title":"J Am Vet Med Assoc"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.7589\/0090-3558-34.2.228","article-title":"First North American field release of a vaccinia-rabies glycoprotein recombinant virus","volume":"34","author":"CA Hanlon","year":"1998","journal-title":"J Wildl Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.2460\/javma.1998.213.10.1407","article-title":"Prevention of the spread of rabies to wildlife by oral vaccination of raccoons in Massachusetts","volume":"213","author":"AH Robbins","year":"1998","journal-title":"J Am Vet Med Assoc"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"752","DOI":"10.7589\/0090-3558-34.4.752","article-title":"Efficacy of an oral vaccinia-rabies glycoprotein recombinant vaccine in controlling epidemic raccoon rabies in New Jersey","volume":"34","author":"DE Roscoe","year":"1998","journal-title":"J Wildl Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1046\/j.1523-1747.2003.12074.x","article-title":"Laboratory acquired infection with recombinant vaccinia virus containing an immunomodulating construct","volume":"120","author":"M Mempel","year":"2003","journal-title":"J Invest Dermatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1056\/NEJMoa010560","article-title":"Human infection due to recombinant vaccinia-rabies glycoprotein virus","volume":"345","author":"CE Rupprecht","year":"2001","journal-title":"N Engl J Med"},{"key":"ref29","first-page":"1204","article-title":"Human vaccinia infection after contact with a raccoon rabies vaccine bait - Pennsylvania, 2009","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/JVI.01552-10","article-title":"Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination","volume":"85","author":"Y Wen","year":"2011","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1073\/pnas.82.13.4360","article-title":"Isolation of cDNA for a human granulocyte-macrophage colony-stimulating factor by functional expression in mammalian cells","volume":"82","author":"F Lee","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.4049\/jimmunol.170.10.5165","article-title":"The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells","volume":"170","author":"TK Means","year":"2003","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1128\/IAI.73.10.6763-6770.2005","article-title":"Cellular mechanisms of the adjuvant activity of the flagellin component FljB of Salmonella enterica serovar typhimurium to potentiate mucosal and systemic responses","volume":"73","author":"O Pino","year":"2005","journal-title":"Infection and Immunity"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.4049\/jimmunol.172.11.6922","article-title":"Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response","volume":"172","author":"A Didierlaurent","year":"2004","journal-title":"J Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1189\/jlb.0105051","article-title":"Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions","volume":"78","author":"H Tsujimoto","year":"2005","journal-title":"J Leukoc Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0264-410X(92)90071-Q","article-title":"Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in mice","volume":"10","author":"J McEwen","year":"1992","journal-title":"Vaccine"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0264-410X(95)00088-I","article-title":"Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection","volume":"14","author":"R Levi","year":"1996","journal-title":"Vaccine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.4049\/jimmunol.169.7.3914","article-title":"Bacterial flagellin is an effective adjuvant for CD4+ T cells in vivo","volume":"169","author":"SJ McSorley","year":"2002","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","article-title":"Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis","volume":"74","author":"AN Honko","year":"2006","journal-title":"Infect Immun"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1128\/IAI.73.10.6763-6770.2005","article-title":"Cellular mechanisms of the adjuvant activity of the flagellin component FljB of Salmonella enterica Serovar Typhimurium to potentiate mucosal and systemic responses","volume":"73","author":"O Pino","year":"2005","journal-title":"Infect Immun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mad.2008.01.009","article-title":"Mucosal adjuvant activity of flagellin in aged mice","volume":"129","author":"JT Bates","year":"2008","journal-title":"Mech Ageing Dev"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1128\/IAI.74.1.694-702.2006","article-title":"A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity","volume":"74","author":"SE Lee","year":"2006","journal-title":"Infect Immun"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CVI.00333-08","article-title":"Flagellin-F1-V Fusion Protein Is an Effective Plague Vaccine in Mice and Two Species of Nonhuman Primates","volume":"16","author":"SB Mizel","year":"2009","journal-title":"Clinical and Vaccine Immunology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.virusres.2005.03.010","article-title":"Comparative pathogenesis of the SAD-L16 strain of rabies virus and a mutant modifying the dynein light chain binding site of the rabies virus phosphoprotein in young mice","volume":"111","author":"P Rasalingam","year":"2005","journal-title":"Virus Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0042-6822(90)90433-R","article-title":"Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19","volume":"175","author":"KK Conzelmann","year":"1990","journal-title":"Virology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1128\/JVI.00357-07","article-title":"Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus","volume":"81","author":"M Faber","year":"2007","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies viruses from cloned cDNA","volume":"13","author":"MJ Schnell","year":"1994","journal-title":"EMBO J"},{"key":"ref48","first-page":"493","article-title":"A simple method of estimating fifty percent end points","volume":"27","author":"LJ Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI31205","article-title":"DC-based cancer vaccines","volume":"117","author":"E Gilboa","year":"2007","journal-title":"J Clin Invest"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-1759(98)00204-X","article-title":"An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow","volume":"223","author":"MB Lutz","year":"1999","journal-title":"J Immunol Methods"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1128\/JVI.00326-10","article-title":"Expression of MIP-1alpha (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells","volume":"84","author":"L Zhao","year":"2010","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0166-0934(02)00249-5","article-title":"An improved method for recovering rabies virus from cloned cDNA","volume":"107","author":"K Inoue","year":"2003","journal-title":"J Virol Methods"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.4049\/jimmunol.171.10.4984","article-title":"Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos","volume":"171","author":"S Agrawal","year":"2003","journal-title":"J Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CVI.00333-08","article-title":"Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates","volume":"16","author":"SB Mizel","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"12093","DOI":"10.1128\/JVI.00406-10","article-title":"Stimulation of human dendritic cells by wild-type and M protein mutant vesicular stomatitis viruses engineered to express bacterial flagellin","volume":"84","author":"M Ahmed","year":"2010","journal-title":"J Virol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1086\/517613","article-title":"A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity","volume":"195","author":"WF McDonald","year":"2007","journal-title":"J Infect Dis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/vim.2009.0107","article-title":"A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice","volume":"23","author":"KN Delaney","year":"2010","journal-title":"Viral Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.1016\/j.vaccine.2012.09.013","article-title":"Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections","volume":"30","author":"G Liu","year":"2012","journal-title":"Vaccine"},{"key":"ref59","first-page":"1","article-title":"Rationale and prospects for rabies elimination in developing countries","volume":"187","author":"FX Meslin","year":"1994","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/BF01317147","article-title":"Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine","volume":"123","author":"KM Charlton","year":"1992","journal-title":"Arch Virol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/vr.139.2.32","article-title":"Progress and setbacks in the oral immunisation of foxes against rabies in Europe","volume":"139","author":"K Stohr","year":"1996","journal-title":"Vet Rec"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7589\/0090-3558-37.1.119","article-title":"Elimination of rabies from red foxes in eastern Ontario","volume":"37","author":"CD MacInnes","year":"2001","journal-title":"J Wildl Dis"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1099\/0022-1317-82-9-2191","article-title":"Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration","volume":"82","author":"A Vos","year":"2001","journal-title":"J Gen Virol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virol.2006.07.037","article-title":"A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice","volume":"356","author":"J Li","year":"2006","journal-title":"Virology"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1016\/j.vaccine.2009.06.062","article-title":"A single immunization with a recombinant canine adenovirus type 2 expressing the seoul virus Gn glycoprotein confers protective immunity against seoul virus in mice","volume":"27","author":"ZG Yuan","year":"2009","journal-title":"Vaccine"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.vaccine.2007.12.050","article-title":"A recombinant pseudorabies virus expressing rabies virus glycoprotein: safety and immunogenicity in dogs","volume":"26","author":"Z Yuan","year":"2008","journal-title":"Vaccine"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Amann R, Rohde J, Wulle U, Conlee D, Raue R, <etal>et al<\/etal>.. (2012) A new rabies vaccine based on a recombinant Orf virus (Parapoxvirus) expressing the rabies virus glycoprotein. J Virol.","DOI":"10.1128\/JVI.02470-12"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virusres.2005.03.017","article-title":"Oral vaccination of dogs with recombinant rabies virus vaccines","volume":"111","author":"CE Rupprecht","year":"2005","journal-title":"Virus Res"},{"key":"ref69","first-page":"233","article-title":"Studies on an inactivated vaccine against rabies virus in domestic animals","volume":"125","author":"F Monaco","year":"2006","journal-title":"Dev Biol (Basel)"},{"key":"ref70","first-page":"206","article-title":"Further studies of sylvatic rabies in the fox (Vulpes vulpes). Vaccination by the oral route","volume":"14","author":"JG Black","year":"1973","journal-title":"Can Vet J"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/oxfordjournals.aje.a112080","article-title":"Determination of the site of oral rabies vaccination","volume":"101","author":"GM Baer","year":"1975","journal-title":"Am J Epidemiol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"S803","DOI":"10.1093\/clinids\/10.Supplement_4.S803","article-title":"Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor)","volume":"10","author":"CE Rupprecht","year":"1988","journal-title":"Rev Infect Dis"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/S0264-410X(01)00186-4","article-title":"Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination","volume":"19","author":"LA Orciari","year":"2001","journal-title":"Vaccine"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0063384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T10:42:34Z","timestamp":1746009754000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0063384"}},"subtitle":[],"editor":[{"given":"Stephen J.","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,20]]},"references-count":73,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0063384","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,20]]}}}